Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000080255-25-000842·Entrada Therapeutics, Inc.
Schedule 13G ownership disclosure
Entrada Therapeutics Inc
COMMON STOCK · CUSIP: 29384C108
Event date: 2025-09-30
- Filing-level shares
- 360,526
- Percent of class
- 0.9%
- T. Rowe Price Associates, Inc.
Shares: 360,526 · Class: 0.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-25-000842
- Form type
- SCHEDULE 13G/A
- Filer
- Entrada Therapeutics, Inc.
- CIK
- CIK 1689375
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership